Leadership at ABSINCGROUP

Our team is composed of seasoned global professionals with deep expertise in regulatory strategy, operations and scientific innovation — spanning drugs, biologics, pharmaceuticals and medical devices from early development through commercialization.

Global biopharma leader with 35+ years of experience launching blockbuster biologics, vaccines and advanced therapies. Former executive at Pfizer, Sanofi, Merck and the Gates Foundation. Expert in FDA/EMA submissions, GMP operations and strategic quality leadership.

Leadership Excellence

Operational strategist and manufacturing systems leader with deep expertise in quality remediation, validation and site readiness. Has led cross-functional teams for FDA/EMA compliance.

Our Team

Dr. Niranjan M. Kumar, PDF, PhD, MBA

Education: PhD | Master’s in Management, Wharton Business School (UPenn)
Experience: 35+ years in regulatory strategy, cGMP operations, and global quality compliance
Expertise: Quality, manufacturing innovation, accelerated market access, and cross-border partnerships.
Global biopharma leader with 35+ years advancing biologics, vaccines, cell & gene therapies, and biosimilars from R&D through commercial launch.
Proven regulatory and quality expert—authored numerous CMC sections for FDA/EMA approvals with a record of zero FDA 483s.
Directed $200M+ cGMP facility buildouts and multiple tech transfers, ensuring late-stage scale-up and commercial readiness.
Delivered 50% yield improvements and 40% cost reductions by transforming complex manufacturing performance through Lean Six Sigma.
Trusted advisor to boards, executives, and investors—bridging science, operations, and regulatory requirements to accelerate global market access.
Values-driven mentor and leader, building diverse, high-performing teams rooted in innovation, accountability, and patient focus.
Skilled in business, technical, and financial due diligence as well as global partnerships.

President & Founding Director

Masters in Management (Wharton Business School, University of Pennsylvania)

Ms. Sheila Smith, MBA

Proven track record in building and nurturing strategic client partnerships
Expert in account growth and consulting delivery management
Focused on ensuring client confidence and long-term relationship success
Skilled in managing complex projects across biopharma, biotech, and pharma sectors
Strong communicator bridging client needs and internal employee teams

Vice President, Human Resources

Mr. Nathan Roy, BS

Executive Business Development, The Wharton School at the University of Pennsylvania, Philadelphia

Specialist in international expansion and cross-regional client acquisition
Drives growth strategies across the U.S., Europe, and MENA regions
Experienced in market entry planning for consulting and CDMO partnerships
Builds and maintains strategic alliances with industry leaders
Expert in identifying new business opportunities and scaling operations

Vice President, Business Development & Marketing

Senior Manufacturing & Quality Leader

Extensive experience in quality gap assessment, remediation, data integrity, validation, and site readiness
Proven ability to lead cross-functional teams for FDA and EMA compliance
Expert in cGMP manufacturing operations and quality system development
Skilled in process optimization and risk mitigation strategies
Hands-on leader focused on operational excellence and regulatory adherence

Operational Strategist and Manufacturing Systems Expert. FDA certified 3rd party consultants for global companies.